Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model. The Dow Jones Industrial Average ( ^DJI) is trading up 12 points at 15,068 as of Wednesday, May 8, 2013, 12:35 p.m. ET. During this time, 288.7 million shares of the 30 Dow components have changed hands vs. an average daily trading volume of 601.1 million. The NYSE advances/declines ratio sits at 1,670 issues advancing vs. 1,254 declining with 121 unchanged.
EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
The Dow component leading the way higher looks to be UnitedHealth Group (NYSE: UNH), which is sporting a $1.21 gain (+2%) bringing the stock to $61.71. This single gain is lifting the Dow Jones Industrial Average by 9.16 points or roughly accounting for 76.3% of the Dow's overall gain. Volume for UnitedHealth Group currently sits at 4.9 million shares traded vs. an average daily trading volume of 6.3 million shares. UnitedHealth Group has a market cap of $61.43 billion and is part of the health care sector and health services industry. Shares are up 11.5% year to date as of Tuesday's close. The stock's dividend yield sits at 1.4%. UnitedHealth Group Incorporated operates as a diversified health and well-being company in the United States. The company has a P/E ratio of 11.7, below the S&P 500 P/E ratio of 17.7. TheStreet Ratings rates UnitedHealth Group as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, attractive valuation levels, largely solid financial position with reasonable debt levels by most measures, increase in stock price during the past year and notable return on equity. We feel these strengths outweigh the fact that the company shows weak operating cash flow.